Advanced search
Publication Cover
Pain Management Volume 3, 2013 - Issue 2
Submit an article Journal homepage
37
Views
0
CrossRef citations to date
0
Altmetric
Case Report

The use of Combined Spinal–Epidural Technique to Compare Intrathecal Ziconotide and Epidural Opioids for Trialing Intrathecal Drug Delivery

Amitabh Gulati1 Department of Anesthesiology & Critical Care, Memorial Sloan–Kettering Cancer Center M308, New York, NY10065, USACorrespondence[email protected]
,
Jeffrey Loh2 Department of Anesthesiology, Weill Medical College, Cornell University, New York, NY, USA
,
Vinay Puttanniah1 Department of Anesthesiology & Critical Care, Memorial Sloan–Kettering Cancer Center M308, New York, NY10065, USA
&
Vivek Malhotra1 Department of Anesthesiology & Critical Care, Memorial Sloan–Kettering Cancer Center M308, New York, NY10065, USA
Pages 123-128 | Published online: 28 Feb 2013

References

  • Christo PJ , MazloomdoostD. Cancer pain and analgesia. Ann. NY Acad. Sci.1138 , 278–298 (2008).
  • Bannwarth B . Risk-benefit assessment of opioids in chronic noncancer pain. Drug Saf.21(4) , 283–296 (1999).
  • Kumar K , KellyM, PirlotT. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg. Neurol.55(2) , 79–86 (2001).
  • Smith HS , DeerTR, StaatsPS, SinghV, SehgalN, CordnerH. Intrathecal drug delivery. Pain Physician11(2 Suppl.) , S89–S104 (2008).
  • Wallace MS , KosekPS, StaatsP, FisherR, SchultzDM, LeongM. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. Pain Med.9(3) , 271–281 (2008).
  • Webster LR , FakataKL, CharapataS, FisherR, MineHartM. Open-label, mulitcenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain. Pain Med.9(3) , 282–290 (2008).
  • Alicino I , GiglioM, MancaF, BrunoF, PuntilloF. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice. Pain153(1) , 245–249 (2012).
  • Wermeling D . Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain. Pharmacotherapy25(8) , 1084–1094 (2005).
  • Staats PS , YearwoodT, CharapataSG et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer of AIDS: a randomized controlled trial. JAMA 291(1) , 63–70 (2004).
  • Deer TR , PragerJ, LevyR et al. Poly-analgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 15(5) , 436–466 (2012).
  • Deer TR , PragerJ, LevyR et al. Polyanalgesic Consensus Conference-2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 15(5) , 420–435 (2012).
  • Rosenblum SM . A randomized, multidose, double-blind study to evaluate the analgesic response and safety of ziconotide intrathecal bolus injection in patients with severe chronic pain. Presented at: North American Neuromodulation Society Meeting. Las Vegas, NV, USA, December 2007 (Absract).
  • Okano D , AkbikH, ZolletR, KhanM, MunirM. Single-shot intrathecal ziconotide to predict its pump infusion effect. Presented at: The 24th Annual Meeting of the American Academy of Pain Medicine. Orlando, FL, USA, 13–16 February 2008 (Abstract 162).
  • Burton AW , DeerT, WallaceMS, RauckRL, GrigsbyE. Considerations and methodology for trialing ziconotide. Pain Physician13 , 23–33 (2010).
  • Rauck RL , WallaceMS, LeongMS et al. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J. Pain Symptom Manage. 31(5) , 393–406 (2006).
  • Wallace MS , RauckRL, FisherR, CharapataSG, EllisD, DissanayakeS. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial. Anesth. Analg.106 , 628–637 (2008).
  • Dupoiron D , BoreF, Lefebvre-KuntzD et al. Ziconotide adverse events in patients with cancer pain: a multicenter observational study of a slow titration, multidrug protocol. Pain Physician 15(5) , 395–403 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.